admin

About admin

This author has not yet filled in any details.
So far admin has created 5 blog entries.

ISK is going to the BIO conference 2016

ISK was selected for the 6th time to represent Israel in the BIO conference which is being held this year in San-Francisco.

29 Mar|

ISK is going to the BIO conference 2015

ISK was selected for the 5th time to represent Israel in the BIO conference in philadelphia

23 Jun|

800,000 USD grant received from Chief scientist

03 May|

Preparing for Phase IIa

03 May|

Clinical trial: Phase I Dose Escalation completed successfully with exciting results

To date, 23 patients with advanced/metastatic solid tumors have been enrolled (3+3 protocol).

Toxicity: MTD has not been reached. Treatment was well-tolerated with no cumulative toxicity.
Pharmacokinetic analysis: AUC, Cmax and t½ were calculated and were dose-dependent and approximately linear.
Efficacy: 5 of 15 evaluable patients have been treated for at least 3 cycles and were considered

01 Apr|